Locations:
SearchAdvertisement
What updated techniques, counseling and a changing workforce could mean
Blinatumomab plus chemotherapy improves overall survival and relapse-free survival over chemotherapy alone
Patients receive specialized inpatient and outpatient care for cellular, gene and immune cell-engaging therapies
Treatment involved checkpoint inhibitor, surgery and intravesical therapy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Researchers Assess Real-Life Experiences of Patients Treated Outside of Clinical Trials
Multi-specialty coordination essential for improving quality of life
Seven-gene biosignature becomes first effective means to reduce over- and under-treatment with radiation therapy
Early intervention helps prevent chronic lymphedema
CAR T-cell therapy, bispecifics and antibody drug conjugates have changed disease management
Approach could help clinicians identify patients at an increased risk of progression who could benefit from more aggressive treatment
Advertisement
Advertisement